Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre study.
Elisabeth M G de VriesMartti FärkkiläPiotr MilkiewiczJohannes Roksund HovBertus EksteenDouglas ThorburnOlivier ChazouillèresAlbert ParesStåle NygårdOdd H GiljaEwa WunschInvernizzi PietroMarco CarboneFrancesca BernuzziKirsten M BobergHelge RøsjøWilliam RosenbergUlrich H BeuersCyriel Y PonsioenTom H KarlsenMette VesterhusPublished in: Liver international : official journal of the International Association for the Study of the Liver (2017)
Our retrospective data validates the predictive utility of ELF test for clinical outcomes in PSC. The clinical utility of biomarkers for fibrosis in patients with PSC should be assessed in prospective patient cohorts.